Lens pseudoexfoliation syndrome
Also known as: Disorder, Syndrome, Diseases, Condition
Methodology & AI Transparency ⓘ
Lens pseudoexfoliation syndrome Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Eye Health, Glaucoma & Vision Disorders practice, Lens pseudoexfoliation syndrome (also termed Disorder or Syndrome) (ICD-10 H26.8) is stratified through AREDS2 macular nutrition [Lens pseudoexfoliation syndrome H26.8], pairing targeted symptom control with longitudinal Best-Corrected Visual Acuity in Lens pseudoexfoliation syndrome (H26.8: & OCT) surveillance.
- 2 Real-world patient consensus: Synonyms for Lens pseudoexfoliation syndrome (H26.8): Disorder, Syndrome, Diseases (Eyes & Vision).
- 3 Typical cash cost range: Workup highlights for Lens pseudoexfoliation syndrome (H26.8): AREDS2 macular nutrition [Lens pseudoexfoliation syndrome H26.8].
- 4 Top reported side effects / signs: Key Eyes & Vision biomarkers for Lens pseudoexfoliation syndrome (H26.8): Intraocular Pressure (IOP) [Lens pseudoexfoliation syndrome H26.8] & Best-Corrected Visual Acuity in Lens pseudoexfoliation syndrome (H26.8: & OCT) (Intact retinal nerve fiber & macula (H26.8)).
Ask our AI Specialists anything about Lens pseudoexfoliation syndrome
What Is Lens pseudoexfoliation syndrome?
Within Eye Health, Glaucoma & Vision Disorders practice, Lens pseudoexfoliation syndrome (also termed Disorder or Syndrome) (ICD-10 H26.8) is stratified through AREDS2 macular nutrition [Lens pseudoexfoliation syndrome H26.8], pairing targeted symptom control with longitudinal Best-Corrected Visual Acuity in Lens pseudoexfoliation syndrome (H26.8: & OCT) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Lens pseudoexfoliation syndrome (H26.8, Eyes & Vision) reflects impaired trabecular meshwork in Lens pseudoexfoliation syndrome (H26.8: aqueous humor outflow). longitudinal control is benchmarked via Intraocular Pressure (IOP) [Lens pseudoexfoliation syndrome H26.8].
Common Symptoms & Clinical Signs
- • Presentation of Lens pseudoexfoliation syndrome (H26.8): gradual blurring, glare/halos in Lens pseudoexfoliation syndrome (H26.8: around nighttime headlights,)
- • Secondary Lens pseudoexfoliation syndrome clinical sign: gritty burning, foreign-body in Lens pseudoexfoliation syndrome (H26.8: sensation, reflex tearing,)
- • Symptom flares in Lens pseudoexfoliation syndrome correlating with Intraocular Pressure (IOP) [Lens pseudoexfoliation syndrome H26.8] deviation outside 10 – 21 mmHg (individualized optic target) (H26.8)
- • Functional eyes & vision impact requiring AREDS2 macular nutrition [Lens pseudoexfoliation syndrome H26.8] evaluation (H26.8)
Lens pseudoexfoliation syndrome Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H26.8 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Lens pseudoexfoliation syndrome H26.8] | 10 – 21 mmHg (individualized optic target) (H26.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Lens pseudoexfoliation syndrome (H26.8: & OCT) | Intact retinal nerve fiber & macula (H26.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Lens pseudoexfoliation syndrome (H26.8: Blood Pressure) | Microvascular retinal protection (H26.8) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Lens pseudoexfoliation syndrome
Treatment selection for Lens pseudoexfoliation syndrome depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Lens pseudoexfoliation syndrome)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Artificial Intelligence-based characterization of therapeutic response in fluid Accordingly, treatment-naïve patients had a significantly higher gain of BCVA with + 4.6 letters compared to + 1.2 letters (p < 0.01). Scientific reports • 2026-02-17 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41703113 ↗ |
| Can This Approach Help? Inside the Latest Research on Correlation Between Blue Fundus Autofluorescence and SD-OCT Measurements of The strong correlation between blue FAF and OCT measurements of GA area supports OCT as a reliable method to measure GA lesion area in clinical trials. American journal of ophthalmology • 2024-10-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 38719131 ↗ |
Lens pseudoexfoliation syndrome Patient Community & “People Like Me” Threads
Filter Lens pseudoexfoliation syndrome community threads and patient logs by age, biological sex, dosage, and treatment duration.